Oral Contraceptive Pills Market 2024 - Share, Leading Companies, Revenue Outlook, and Growth Forecast Until 2033

The oral contraceptive pills market size has grown rapidly in recent years. It will grow from $23.66 billion in 2023 to $27.12 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing awareness, rising women's health concerns, government initiatives, changing lifestyles, market expansion.

The oral contraceptive pills market size is expected to see rapid growth in the next few years. It will grow to $47.15 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to growing population, women's empowerment, rising healthcare expenditure, advancements in healthcare infrastructure, expanding product portfolio. Major trends in the forecast period include focus on minimizing side effects and hormonal disruption, emergence of non-hormonal and natural contraceptive alternatives, shift towards continuous and tailored contraceptive regimens, increasing awareness and education initiatives, rise in female empowerment and involvement in contraceptive choices.

Market Overview -
Oral contraceptive pills refer to a contraceptive tablet that contains hormones that prevent the release of eggs from the ovaries. Oral contraceptives typically contain progestin and estrogen. Also known as the birth control pill it comprises hormones that prevent the emergence of eggs from the ovaries. Most oral contraceptives involve estrogen and progestin.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

Role Of Oral Contraceptive Pills In Preventing Unintended Pregnancies
The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years. An unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives. According to the World Health Organization (WHO), 74 million women living in low-middle-income economies register unplanned pregnancies every year globally. The WHO's research noticed that 4,794 women had unplanned pregnancies after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.

Competitive Landscape -
Major companies operating in the oral contraceptive pills market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Abbvie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Church and Dwight Co Inc., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Ferring B.V, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Vardhaman Lifecare Pvt. Ltd., Glenmark Pharmaceuticals, Piramal Enterprises Ltd., Mankind Pharma Ltd., Sopharma AD, Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Syzygy Healthcare, V Care Pharma, Actavis plc, Mylan N.V.

Innovations In Oral Contraceptive Pills For Enhanced Accessibility And Convenience
Major institutes and companies operating in the oral contraceptive pill sector are focusing on developing innovative solutions for oral contraceptive pills. For instance, in July 2022, HRA Pharma, a France based innovative healthcare company, developed an over-the-counter birth control pill called Opill. HRA Pharma has applied to the Food and Drug Administration in the United States. Opil is a progestin-based contraceptive that helps people access contraception without facing any difficulty.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Key Segments -
The oral contraceptive pills market covered in this report is segmented -
1) By Type: Combination, Progestin Only, Other Types
2) By Category: Generic, Branded
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.